Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways

Cisplatin, as the first-line anti-tumor agent, is widely used for treatment of a variety of malignancies including non-small cell lung cancer (NSCLC). However, the acquired resistance has been a major obstacle for the clinical application. Scutellarin is a active flavone extracted from Erigeron brev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chao-Yue, Zhu, Ying, Li, Xiao-Feng, Wang, Xie-Qi, Tang, Li-Peng, Su, Zu-Qing, Li, Cai-Yun, Zheng, Guang-Juan, Feng, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816782/
https://www.ncbi.nlm.nih.gov/pubmed/29487530
http://dx.doi.org/10.3389/fphar.2018.00092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816782/
https://www.ncbi.nlm.nih.gov/pubmed/29487530
http://dx.doi.org/10.3389/fphar.2018.00092

Ejemplares similares